Appelbaum P C, Kaufmann C S, Depenbusch J W
J Clin Microbiol. 1985 Jun;21(6):894-8. doi: 10.1128/jcm.21.6.894-898.1985.
In this study, we evaluated the ability of a 4-h enzyme assay kit system, the RapID ANA method (Innovative Diagnostic Systems, Inc., Atlanta, Ga.) to accurately and reproducibly identify a spectrum of clinically significant anaerobic bacteria in two separate institutions. Additional tests were performed as required. Of a total of 188 organisms tested at Hershey Medical Center (HMC), 86.2% were correctly identified to species level without additional tests, 5.9% required extra tests for correct identification, and 8.0% were misidentified. Of 53 strains tested at Johns Hopkins Hospital (JHH), 52.8% were correctly identified without extra tests, 28.3% required extra tests for correct identification, and 18.9% were misidentified. Of 21 organisms tested at both institutions, those tested at JHH required additional tests for correct identification in 38.1% of cases, compared with 9.5% at HMC. Misidentification rates were identical (9.5%) in both centers. Of strains tested at HMC only, 86.8% were correctly identified without extra tests, 5.4% were identified with additional tests, and 7.8% were misidentified: corresponding data for JHH were 53.1, 21.9, and 25.0%, respectively. Of 53 strains tested in triplicate at JHH, 56.7% yielded the same result on each occasion, 37.7% were identical in two of three tests, and 5.7% gave different results on each of three occasions. Discrepancies between identification rates at HMC and JHH may be explained by differences in species tested (more commonly encountered species were tested at HMC) and interpretation of reactions by the two different readers. The RapID ANA method has the potential for rapid identification of clinically isolated anaerobes; however, accuracy and reproducibility may vary as a function of the specific laboratory setting.
在本研究中,我们评估了一种4小时酶检测试剂盒系统——RapID ANA方法(创新诊断系统公司,佐治亚州亚特兰大)在两个不同机构准确且可重复地鉴定一系列具有临床意义的厌氧细菌的能力。根据需要进行了额外的检测。在 Hershey 医疗中心(HMC)共检测了188株菌株,其中86.2%无需额外检测即可正确鉴定到种水平,5.9%需要额外检测才能正确鉴定,8.0%被错误鉴定。在约翰霍普金斯医院(JHH)检测的53株菌株中,52.8%无需额外检测即可正确鉴定,28.3%需要额外检测才能正确鉴定,18.9%被错误鉴定。在两个机构都检测的21株菌株中,在JHH检测的菌株有38.1%需要额外检测才能正确鉴定,而在HMC这一比例为9.5%。两个中心的错误鉴定率相同(9.5%)。仅在HMC检测的菌株中,86.8%无需额外检测即可正确鉴定,5.4%通过额外检测鉴定出来,7.8%被错误鉴定;JHH的相应数据分别为53.1%、21.9%和25.0%。在JHH对53株菌株进行了三次重复检测,56.7%每次检测结果相同,37.7%在三次检测中有两次结果相同,5.7%三次检测结果均不同。HMC和JHH鉴定率的差异可能是由于检测的菌种不同(HMC检测的是更常见的菌种)以及两位不同的读片者对反应的解读不同所致。RapID ANA方法有快速鉴定临床分离厌氧菌的潜力;然而,准确性和可重复性可能因具体实验室环境而异。